The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine
Open accessAbstract
Antimicrobial peptides (AMPs) represent a vast array of molecules produced by virtually all living organisms as natural barriers against infection. Among AMP sources, an interesting class regards the food-derived bioactive agents. The whey protein lactoferrin (Lf) is an iron-binding glycoprotein that plays a significant role in the innate immune system, and is considered as an important host defense molecule. In search for novel antimicrobial agents, Lf offers a new source with potential pharmaceutical applications. The Lf-derived peptides Lf(1–11), lactoferricin (Lfcin) and lactoferrampin exhibit interesting and more potent antimicrobial actions than intact protein. Particularly, Lfcin has demonstrated strong antibacterial, anti-fungal and antiparasitic activity with promising applications both in human and veterinary diseases (from ocular infections to osteo-articular, gastrointestinal and dermatological diseases).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
Yamauchi, K., Tomita, M., Giehl, T. J., & Ellison, R. T. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.719-728.1993 · Cited by 500
Antiviral properties of lactoferrin--a natural immunity molecule
Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P. (2011) · Molecules · doi:10.3390/molecules16086992 · Cited by 356
Lohner, K., & Blondelle, S. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053764576 · Cited by 222
Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K., & Yamaguchi, H. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01147.x · Cited by 116
Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
Brouwer, C. P. J. M., Rahman, M., & Welling, M. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.017 · Cited by 90
Research works printed but not linked: 123
- Reddy, 2004, Antimicrobial peptides: Premises and promises, Int. J. Antimicrob. Agents, 24, 536, 10.1016/j.ijantimicag.2004.09.005 · DOI · Paper page
- Tam, 2015, Antimicrobial peptides from plants, Pharmaceuticals, 8, 711, 10.3390/ph8040711 · DOI · Paper page
- Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 24, 1551, 10.1038/nbt1267 · DOI · Paper page
- Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
- Wang, 2009, APD2: The updated antimicrobial peptide database and its application in peptide design, Nucleic Acids Res., 37, D933, 10.1093/nar/gkn823 · DOI · Paper page
- Gill, 2015, Antibiotic adjuvants: Diverse strategies for controlling drug-resistant pathogens, Chem. Biol. Drug Des., 85, 56, 10.1111/cbdd.12478 · DOI · Paper page
- Anuforom, 2015, The immune response and antibacterial therapy, Med. Microbiol. Immunol., 204, 151, 10.1007/s00430-014-0355-0 · DOI
- Korhonen, 2003, Food-derived bioactive peptides—Opportunities for designing future foods, Curr. Pharm. Des., 9, 1297, 10.2174/1381612033454892 · DOI · Paper page
- Atanasova, 2014, Proteolytic and antimicrobial activity of lactic acid bacteria grown in goat milk, Biotechnol. Biotechnol. Equip., 28, 1073, 10.1080/13102818.2014.971487 · DOI · Paper page
- Nongonierma, 2015, Bioactive properties of milk proteins in humans: A review, Peptides, 73, 20, 10.1016/j.peptides.2015.08.009 · DOI
- Ng, 2015, Antiviral activities of whey proteins, Appl. Microbiol. Biotechnol., 99, 6997, 10.1007/s00253-015-6818-4 · DOI
- Fliss, 2014, Antimicrobial peptides of dairy proteins: From fundamental to applications, Food Rev. Int., 30, 134, 10.1080/87559129.2014.896017 · DOI
- Fliss, 2014, MilkAMP: A comprehensive database of antimicrobial peptides of dairy origin, Dairy Sci. Technol., 94, 181, 10.1007/s13594-013-0153-2 · DOI
- Andersen, 2003, Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir, Antivir. Res., 58, 209, 10.1016/S0166-3542(02)00214-0 · DOI
- Shestakov, 2012, Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice, Antivir. Res., 93, 340, 10.1016/j.antiviral.2012.01.003 · doi:10.1016/j.antiviral.2012.01.003
- Mistry, 2007, The anti-papillomavirus activity of human and bovine lactoferricin, Antivir. Res., 75, 258, 10.1016/j.antiviral.2007.03.012 · DOI
- Omata, 2001, Reduction of the Infectivity of Toxoplasma gondii and Eimeria stiedai Sporozoites by Treatment with Bovine Lactoferricin, J. Vet. Med. Sci., 63, 187, 10.1292/jvms.63.187 · DOI
- Zhang, 2014, Anticancer effects of lactoferrin: Underlying mechanisms and future trends in cancer therapy, Nutr. Rev., 72, 763, 10.1111/nure.12155 · DOI
- Riedl, 2014, Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine, BioMetals, 27, 981, 10.1007/s10534-014-9749-0 · doi:10.1007/s10534-014-9749-0
- Kim, 2013, Lactoferricin mediates anti-inflammatory and anti-catabolic effects via inhibition of IL-1 and LPS activity in the intervertebral disc, J. Cell. Physiol., 228, 1884, 10.1002/jcp.24350 · DOI
- Embleton, 2013, Lactoferrin: Antimicrobial activity and therapeutic potential, Semin. Fetal Neonat. Med., 18, 143, 10.1016/j.siny.2013.02.001 · DOI
- Leboffe, 2009, Antifungal and antiparasitic activities of lactoferrin, Anti-Infect. Agents Med. Chem., 8, 114, 10.2174/187152109787846105 · DOI
- 2014, Immunomodulatory effects of lactoferrin, Acta Pharmacol. Sin., 35, 557, 10.1038/aps.2013.200 · DOI · Paper page
- Kanwar, 2015, Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions, Molecules, 20, 9703, 10.3390/molecules20069703 · DOI
- Brock, 2012, Lactoferrin-50 years on, Biochem. Cell Biol., 90, 245, 10.1139/o2012-018 · DOI
- Arnold, 1980, Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms, Infect. Immun., 28, 893, 10.1128/iai.28.3.893-898.1980 · DOI · Paper page
- Ochoa, 2012, Clinical studies of lactoferrin in children, Biochem. Cell Biol., 90, 457, 10.1139/o11-087 · DOI
- Sharma, 2016, Lactoferrin and neonatology-role in neonatal sepsis and necrotizing enterocolitis: Present, past and future, J. Mater. Fetal Neonat. Med., 29, 763, 10.3109/14767058.2015.1017463 · DOI
- Ochoa, 2008, Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children, Clin. Infect. Dis., 46, 1881, 10.1086/588476 · DOI
- Masci, 2000, Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme, AIDS, 14, 2403, 10.1097/00002030-200010200-00023 · DOI
- 2008, Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth—A pilot study, Gerodontology, 25, 3, 10.1111/j.1741-2358.2007.00197.x · doi:10.1111/j.1741-2358.2007.00197.x
- Kuipers, 2002, Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis, Drug Deliv., 9, 31, 10.1080/107175402753413154 · DOI · Paper page
- Wakabayashi, 2009, Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia, Antimicrob. Agents Chemother., 53, 3308, 10.1128/AAC.01688-08 · DOI
- Planas, 1999, Effects of topical application of free and liposome-encapsulated lactoferrin and lactoperoxidase on oral microbiota and dental caries in rats, Arch. Oral Biol., 44, 901, 10.1016/S0003-9969(99)00092-8 · doi:10.1016/s0003-9969(99)00092-8
- Yadav, 2014, Effect of periodontal therapy on lactoferrin levels in gingival crevicular fluid, Aust. Dent. J., 59, 314, 10.1111/adj.12203 · DOI
- Sachdeva, 2014, Efficacy of fermented milk and whey proteins in helicobacter pylori eradication: A review, World J. Gastroenterol., 20, 724, 10.3748/wjg.v20.i3.724 · DOI
- Dial, 1998, Antibiotic properties of bovine lactoferrin on Helicobacter pylori, Dig. Dis. Sci., 43, 2750, 10.1023/A:1026675916421 · DOI
- Vitetta, 2013, The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: A double blind randomized study, Complement. Ther. Med., 21, 164, 10.1016/j.ctim.2012.12.006 · DOI
- Leonardi, 2007, Helicobacter pylori eradication: A randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics, Am. J. Gastroenterol., 102, 951, 10.1111/j.1572-0241.2007.01085.x · DOI
- Nappi, 2009, Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: A prospective controlled randomized study, Acta Obstet. Gynecol. Scand., 88, 1031, 10.1080/00016340903117994 · DOI
- Manzoni, 2009, Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial, JAMA J. Am. Med. Assoc., 302, 1421, 10.1001/jama.2009.1403 · DOI · Paper page
- Sinha, M., Kaushik, S., Kaur, P., Sharma, S., and Singh, T.P. (2013). Antimicrobial Lactoferrin Peptides: The Hidden Players in the Protective Function of a Multifunctional Protein. Int. J. Pept., 2013. · DOI
- Ulvatne, 2004, Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis, FEMS Microbiol. Lett., 237, 377
- Lupetti, 2000, Candidacidal activities of human lactoferrin peptides derived from the N terminus, Antimicrob. Agents Chemother., 44, 3257, 10.1128/AAC.44.12.3257-3263.2000 · DOI
- Lupetti, 2002, Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin, Antimicrob. Agents Chemother., 46, 1634, 10.1128/AAC.46.6.1634-1639.2002 · DOI
- Lupetti, 2003, Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species, Antimicrob. Agents Chemother., 47, 262, 10.1128/AAC.47.1.262-267.2003 · DOI
- Nibbering, 2001, Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria, Infect. Immun., 69, 1469, 10.1128/IAI.69.3.1469-1476.2001 · DOI · Paper page
- Stallmann, 2003, Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1–11 (hLF1–11) from calcium phosphate bone substitutes, J. Antimicrob. Chemother., 52, 853, 10.1093/jac/dkg443 · doi:10.1093/jac/dkg443
- Stallmann, 2004, Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1–11-or gentamicin-containing calcium phosphate cement, J. Antimicrob. Chemother., 54, 472, 10.1093/jac/dkh346 · DOI
- Faber, 2005, Comparable efficacies of the antimicrobial peptide human lactoferrin 1–11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model, Antimicrob. Agents Chemother., 49, 2438, 10.1128/AAC.49.6.2438-2444.2005 · DOI
- Nibbering, 2004, 99mTc-labeled UBI 29–41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus, J. Nucl. Med., 45, 321
- Dijkshoorn, 2004, The synthetic N-terminal peptide of human lactoferrin, hLF(1–11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii, Antimicrob. Agents Chemother., 48, 4919, 10.1128/AAC.48.12.4919-4921.2004 · DOI
- Brouwer, 2008, Various routes of administration of 99mTc-labeled synthetic lactoferrin antimicrobial peptide hLF 1–11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice, Peptides, 29, 1109, 10.1016/j.peptides.2008.03.003 · DOI
- Van der Velden, W.J., van Iersel, T.M., Blijlevens, N.M., and Donnelly, J.P. (2009). Safety and tolerability of the antimicrobial peptide human lactoferrin 1–11 (hLF1–11). BMC Med., 7. · DOI
- Bellamy, 1992, Identification of the bactericidal domain of lactoferrin, Biochim. Biophys. Acta (BBA) Protein Struct. Mol., 1121, 130
- Vorland, 1998, Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin, Scand. J. Infect. Dis., 30, 513, 10.1080/00365549850161557 · DOI
- Hunter, 2005, Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent, Antimicrob. Agents Chemother., 49, 3387, 10.1128/AAC.49.8.3387-3395.2005 · DOI
- Epand, 1999, Diversity of antimicrobial peptides and their mechanisms of action, Biochim. Biophys. Acta Biomembr., 1462, 11, 10.1016/S0005-2736(99)00198-4 · DOI · Paper page
- Gifford, 2005, Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties, Cell. Mol. Life Sci., 62, 2588, 10.1007/s00018-005-5373-z · DOI · Paper page
- Silva, 2014, Killing of Mycobacterium avium by Lactoferricin peptides: Improved activity of arginine- and d-amino-acid-containing molecules, Antimicrob. Agents Chemother., 58, 3461, 10.1128/AAC.02728-13 · DOI
- Bellamy, 1992, Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin, J. Appl. Bacteriol., 73, 472, 10.1111/j.1365-2672.1992.tb05007.x · DOI · Paper page
- Ulvatne, 2001, Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes, FEBS Lett., 492, 62, 10.1016/S0014-5793(01)02233-5 · DOI
- Kang, 1996, Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin, Int. J. Pept. Protein Res., 48, 357, 10.1111/j.1399-3011.1996.tb00852.x · DOI
- Rekdal, 2002, The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin, J. Pept. Sci., 8, 36, 10.1002/psc.365 · doi:10.1002/psc.365
- Rekdal, 2002, Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity, Biochem. Cell Biol., 80, 65, 10.1139/o01-236 · DOI
- Liu, 2011, Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides, BioMetals, 24, 1069, 10.1007/s10534-011-9465-y · doi:10.1007/s10534-011-9465-y
- Tu, Y.H., Ho, Y.H., Chuang, Y.C., Chen, P.C., and Chen, C.S. (2011). Identification of lactoferricin B intracellular targets using an Escherichia coli proteome chip. PLoS ONE, 6. · DOI
- Ho, Y.H., Sung, T.C., and Chen, C.S. (2012). Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB. Mol. Cell. Proteom., 11. · DOI
- Shinoda, 1996, Effects of Lactoferrin and Lactoferricin® on the Release of Interleukin 8 from Human Polymorphonuclear Leukocytes, Biosci. Biotechnol. Biochem., 60, 521, 10.1271/bbb.60.521 · DOI
- Samuelsen, 2004, Anti-complement effects of lactoferrin-derived peptides, FEMS Immunol. Med. Microbiol., 41, 141, 10.1016/j.femsim.2004.02.006 · DOI
- Kuwata, 1998, Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin, Biochim. Biophys. Acta Protein Struct. Mol. Enzymol., 1429, 129, 10.1016/S0167-4838(98)00224-6 · DOI · Paper page
- Wakabayashi, 1999, N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity, Antimicrob. Agents Chemother., 43, 1267, 10.1128/AAC.43.5.1267 · DOI
- Zweytick, 2006, Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity, Biochim. Biophys. Acta (BBA) Biomembr., 1758, 1426, 10.1016/j.bbamem.2006.02.032 · DOI
- Bellamy, 1993, Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin, Med. Microbiol. Immunol., 182, 97, 10.1007/BF00189377 · DOI · Paper page
- Nazmi, 2005, Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli, Peptides, 26, 1537, 10.1016/j.peptides.2005.02.011 · DOI
- Wakabayashi, 1998, Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds, Antimicrob. Agents Chemother., 42, 1587, 10.1128/AAC.42.7.1587 · DOI
- Vorland, 1999, Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus, Scand. J. Infect. Dis., 31, 173, 10.1080/003655499750006236 · DOI
- Oo, 2010, Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection, J. Antimicrob. Chemother., 65, 1243, 10.1093/jac/dkq106 · DOI
- Longhi, 2009, Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli, J. Antibiot., 62, 109, 10.1038/ja.2008.22 · DOI
- Wakabayashi, 2002, Increased Staphylococcus-killing activity of an antimicrobial peptide, lactoferricin B, with minocycline and monoacylglycerol, Biosci. Biotechnol. Biochem., 66, 2161, 10.1271/bbb.66.2161 · doi:10.1271/bbb.66.2161
- 2006, Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica, Biochem. Cell Biol., 84, 327
- Pellegrini, 2008, Synergistic effect between different milk-derived peptides and proteins, J. Dairy Sci., 91, 2184, 10.3168/jds.2007-0037 · DOI
- Nazmi, 2010, Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli, Biometals, 23, 569, 10.1007/s10534-010-9306-4 · DOI
- Murata, 2013, Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin, J. Dairy Sci., 96, 4891, 10.3168/jds.2013-6612 · DOI
- Turchany, 1995, Giardicidal activity of lactoferrin and N-terminal peptides, Infect. Immun., 63, 4550, 10.1128/iai.63.11.4550-4552.1995 · DOI
- Tanaka, 1995, Toxoplasma gondii: Parasiticidal effects of bovine lactoferricin against parasites, Exp. Parasitol., 81, 614, 10.1006/expr.1995.1157 · DOI
- Isamida, 1998, Protective effect of lactoferricin against Toxoplasma gondii infection in mice, J. Vet. Med. Sci., 60, 241, 10.1292/jvms.60.241 · DOI
- Sengupta, 2012, Effects of lactoferricin B against keratitis-associated fungal biofilms, J. Infect. Chemother., 18, 698, 10.1007/s10156-012-0398-3 · DOI
- Yan, 2013, Bovine lactoferricin is anti-inflammatory and anti-catabolic in human articular cartilage and synovium, J. Cell. Physiol., 228, 447, 10.1002/jcp.24151 · doi:10.1002/jcp.24151
- Teraguchi, 1994, The bacteriostatic effects of orally administered bovine lactoferrin on intestinal Enterobacteriaceae of SPF mice fed bovine milk, Biosci. Biotechnol. Biochem., 58, 482, 10.1271/bbb.58.482 · doi:10.1271/bbb.58.482
- Teraguchi, 1995, Bacteriostatic effect of orally administered bovine lactoferrin on proliferation of Clostridium species in the gut of mice fed bovine milk, Appl. Environ. Microbiol., 61, 501, 10.1128/aem.61.2.501-506.1995 · DOI
- Wakabayashi, 2000, Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models, J. Antimicrob. Chemother., 46, 595, 10.1093/jac/46.4.595 · DOI
- Lacasse, 2008, Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens, J. Anim. Sci., 86, 66, 10.2527/jas.2007-0216 · DOI
- Kawai, 2003, Effect of infusing lactoferrin hydrolysate into bovine mammary glands with subclinical mastitis, Vet. Res. Commun., 27, 539, 10.1023/A:1026039522286 · DOI
- Kawai, 2007, Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils, Zoonoses Public Health, 54, 160, 10.1111/j.1863-2378.2007.01031.x · DOI
- Zhang, 2007, Mammary gland expression of antibacterial peptide genes to inhibit bacterial pathogens causing mastitis, J. Dairy Sci., 90, 5218, 10.3168/jds.2007-0301 · DOI
- Tang, 2011, Dietary bovine lactoferricin improved gut microflora, benefited intestinal mucosal morphology and inhibited circular cytokines delivery in 21-day weaned piglets, J. Appl. Anim. Res., 39, 153, 10.1080/09712119.2011.565570 · DOI
- Tang, 2009, Effects of dietary supplementation with an expressed fusion peptide bovine lactoferricin-lactoferrampin on performance, immune function and intestinal mucosal morphology in piglets weaned at age 21 d, Br. J. Nutr., 101, 998, 10.1017/S0007114508055633 · DOI · Paper page
- Tang, 2012, Dietary supplementation with bovine lactoferrampin-lactoferricin produced by Pichia pastoris fed-batch fermentation affects intestinal microflora in weaned piglets, Appl. Biochem. Biotechnol., 168, 887, 10.1007/s12010-012-9827-0 · DOI
- Tang, 2012, Dietary supplementation with recombinant lactoferrampin-lactoferricin improves growth performance and affects serum parameters in piglets, J. Anim. Vet. Adv., 11, 2548, 10.3923/javaa.2012.2548.2555 · doi:10.3923/javaa.2012.2548.2555
- Hou, 2011, Effects of lactoferricin B and cecropin P1 on growth performance, faecal score and dry matter in weaned piglets orally challenged with enterotoxigenic Escherichia coli F4, J. Food Agric. Environ., 9, 275
- Vercelli, 2015, Use of lactoferricin, verbascoside and glycerophosphoinositol emulsion in otitis externa treatment: A pilot study, Veterinaria, 29, 49
- Quintieri, 2012, Antimicrobial efficacy of pepsin-digested bovine lactoferrin on spoilage bacteria contaminating traditional Mozzarella cheese, Food Microbiol., 31, 64, 10.1016/j.fm.2012.02.015 · doi:10.1016/j.fm.2012.02.015
- Caputo, 2015, Pepsin-digested bovine lactoferrin prevents Mozzarella cheese blue discoloration caused by Pseudomonas fluorescens, Food Microbiol., 46, 15, 10.1016/j.fm.2014.06.021 · doi:10.1016/j.fm.2014.06.021
- Paul, 2010, Hydrolytic breakdown of lactoferricin by lactic acid bacteria, J. Ind. Microbiol. Biotechnol., 37, 173, 10.1007/s10295-009-0660-6 · DOI
- Enrique, 2009, Selectivity and antimicrobial action of bovine lactoferrin derived peptides against wine lactic acid bacteria, Food Microbiol., 26, 340, 10.1016/j.fm.2008.11.003 · DOI
- Marcos, 2006, Activity and mode of action against fungal phytopathogens of bovine lactoferricin-derived peptides, J. Appl. Microbiol., 101, 1199, 10.1111/j.1365-2672.2006.03089.x · DOI
- Baruzzi, 2015, Efficacy of lactoferricin B in controlling ready-to-eat vegetable spoilage caused by Pseudomonas spp., Int. J. Food Microbiol., 215, 179, 10.1016/j.ijfoodmicro.2015.09.017 · DOI
- Venkitanarayanan, 1999, Antibacterial effect of lactoferricin B on Escherichia coli O157:H7 in ground beef, J. Food Prot., 62, 747, 10.4315/0362-028X-62.7.747 · doi:10.4315/0362-028x-62.7.747
- Murdock, 2010, The pepsin hydrolysate of bovine lactoferrin causes a collapse of the membrane potential in Escherichia coli O157:H7, Probiot. Antimicrob. Proteins, 2, 112, 10.1007/s12602-010-9039-2 · DOI
- Ransom, 2003, Comparison of intervention technologies for reducing Escherichia coli O157:H7 on beef cuts and trimmings, Food Prot. Trends, 23, 24
- Calzada, 2012, Effect of lactoferrin and its derivatives against gram-positive bacteria in vitro and, combined with high pressure, in chicken breast fillets, Meat Sci., 90, 71, 10.1016/j.meatsci.2011.06.003 · DOI
- Calzada, 2012, Effect of lactoferrin and its derivatives, high hydrostatic pressure, and their combinations, on Escherichia coli O157:H7 and Pseudomonas fluorescens in chicken filets, Innov. Food Sci. Emerg. Technol., 13, 51, 10.1016/j.ifset.2011.07.016 · DOI
- Morales, 2009, Bactericidal activity of lactoferrin and its amidated and pepsin-digested derivatives against Pseudomonas fluorescens in ground beef and meat fractions, J. Food Prot., 72, 760, 10.4315/0362-028X-72.4.760 · DOI
- Groenink, 2004, Lactoferrampin: A novel antimicrobial peptide in the N1-domain of bovine lactoferrin, Peptides, 25, 177, 10.1016/j.peptides.2003.12.006 · DOI · Paper page
- Haney, 2007, Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin, Biochim. Biophys. Acta Biomembr., 1768, 2355, 10.1016/j.bbamem.2007.04.018 · DOI
- Rastogi, N., Nagpal, N., Alam, H., Pandey, S., Gautam, L., Sinha, M., Shin, K., Manzoor, N., Virdi, J.S., and Kaur, P. (2014). Preparation and antimicrobial action of three tryptic digested functional molecules of bovine lactoferrin. PLoS ONE, 9. · DOI
- Hammami, 2013, Isolation and identification of antimicrobial peptides derived by peptic cleavage of whey protein isolate, J. Funct. Foods, 5, 706, 10.1016/j.jff.2013.01.014 · DOI
- Japelj, 2010, Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo, Antimicrob. Agents Chemother., 55, 218
- Przysiecka, 2015, Viral and other cell-penetrating peptides as vectors of therapeutic agents in medicine, J. Pharmacol. Exp. Ther., 354, 32, 10.1124/jpet.115.223305 · DOI
- Nazmi, 2010, Microbicidal effect of the lactoferrin peptides Lactoferricin17–30, Lactoferrampin265–284, and Lactoferrin chimera on the parasite Entamoeba histolytica, BioMetals, 23, 563, 10.1007/s10534-010-9295-3 · DOI
- Vidal, 2014, Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin, BioMetals, 27, 969, 10.1007/s10534-014-9775-y · DOI
- Bolscher, 2012, Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans, Biochem. Cell Biol., 90, 378, 10.1139/o11-085 · DOI
Cited by
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Nielsen, S. D., Beverly, R. L., Qu, Y., & Dallas, D. C. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.04.056 · Cited by 494
Hossain, T. J. (2024) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2024.00035 · Cited by 392
Antifungal Peptides as Therapeutic Agents
Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 264
Emerging Antifungal Targets and Strategies
Ivanov, M., Ćirić, A., & Stojković, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052756 · Cited by 160
Cegolon, L., Mirandola, M., Salaris, C., Salvati, M. V., Mastrangelo, G., & Salata, C. (2021) · Pathogens · doi:10.3390/pathogens10020233 · Cited by 30
Díaz-Godínez, C., González-Galindo, X., Meza-Menchaca, T., Bobes, R. J., de la Garza, M., León-Sicairos, N., Laclette, J. P., & Carrero, J. C. (2019) · Bioscience Reports · doi:10.1042/bsr20180850 · Cited by 23
Metadata
- Authors
- Bruni, N., Capucchio, M., Biasibetti, E., Pessione, E., Cirrincione, S., Giraudo, L., Corona, A., & Dosio, F.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2016-06-11
- Volume
- 21
- Issue
- 6
- Pages
- 752
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2417653920
- Cited by
- 236
- References
- 7
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.